HORMONAL BALANCE AND RECEPTOR STATUS IN PATIENTS WITH UTERINE MYOMA CONCURRENT WITH ENDOMETRIAL HYPERPLASIA AFTER UTERINE ARTERY EMBOLIZATION
- Autores: DOBROKHOTOVA Y.E1, LITVINOVA N.A1, SAPRYKINA L.V1, DEMURA T.A2
-
Afiliações:
- N.I. Pirogov Russian National Research Medical University
- I.M. Sechenov First Moscow State Medical University
- Edição: Nº 4-2 (2012)
- Páginas: 46-50
- Seção: Articles
- URL: https://journals.eco-vector.com/0300-9092/article/view/246732
- ID: 246732
Citar
Texto integral
Acesso aberto
Acesso está concedido
Acesso é pago ou somente para assinantes
Resumo
Objective. To study the hormonal background and receptor status in premenopausal patients with uterine myoma concurrent with endometrial hyperplasia in the postembolization period. Subjects and methods. Eighty-one premenopausal patients with uterine myoma concurrent with endometrial hyperplasia (EH) were examined. All the patients underwent uterine artery embolization (UAE). Thirty-nine patients received dydrogesterone in the postembolization period. Results. Six months after UAE, there were clinical manifestations and histological and ultrasound signs in none of the patients. Conclusion. The hormonal background and receptor status in patients with uterine myoma concurrent with postembolization EH points to the necessity of using dydrogesterone in this category of patients.
Palavras-chave
Texto integral
Sobre autores
Yu. DOBROKHOTOVA
N.I. Pirogov Russian National Research Medical University
N. LITVINOVA
N.I. Pirogov Russian National Research Medical University
L. SAPRYKINA
N.I. Pirogov Russian National Research Medical University
Email: lioudsap@yandex.ru
T. DEMURA
I.M. Sechenov First Moscow State Medical University
Bibliografia
- Артымук Н.В., Шакирова Е.А. Особенности гиперпластических процессов эндометрия и гормональный статус у пациенток с гипоталамическим синдромом // Медицина в Кузбассе. - 2004. — № 11. - С. 5-7.
- Бочкарева Н.В. Особенности метаболизма и рецепции эстрогенов при гиперпластических процессах и раке эндометрия: Автореф. дис..д.м.н. - Томск, 2007. - 40 с.
- Мустафаева А.С. Оптимизация тактики ведения гиперпластических процессов эндометрия у женщин репродуктивного возраста: Автореф. дис.канд. мед. наук - Алматы, 2010.
- Чепик О.Ф. Морфогенез гиперпластических процессов эндометрия // Практическая онкология. - 2004. - Т. 5. -№ 1. - С. 9-15.
- Amant F., Moerman P., Neven P. et al. Endometrial cancer // Lancet. - 2005. - Vol. 366. - P. 491-505.
- Archer D.F. Neoplasia of the female reproductive tract: effects of hormone therapy // Endocrine - 2004. - Vol. 24. - P. 259-263.
- Enmark E., Gustafsson J.A. Oestrogen receptors - an overview // Journal of Internal. Medicine. — 1999. — Vol. 2. — P. 133-138.
- Horn L.C., Dietel M., Einenkel J. Hormone replacement therapy (HRT) and endometrial morphology under consideration of the different molecular pathways in endometrial carcinogenesis // Eur. J. Obstet. Gynecol. Reprod. Biol. — 2005. - Vol. 122. -P. 4-12
- Rudnicka E., Wierzba W., Radowicki S. Evaluation of endometrial histologic morphology in patients with polycystic ovary syndrome // Ginekol. Pol. - 2009. - Vol. 80, № 2. - P. 103-106.
Arquivos suplementares
